REMUNERATION for Australian community pharmacies will drop by 19c per prescription under the next round of price disclosure for the Pharmaceutical Benefits Scheme which becomes effective 01 Oct.
The Pharmacy Guild has calculated the impact of the changes which will see further originator brands excluded from price calculations, with a further estimate that reduced trading terms will also impact gross profit by 5c per script.
That's on top of a 24c impact from the Apr round of price disclosure.
The Guild is advising pharmacies to plan their stock levels ahead of 01 Oct which is a Mon, potentially impacting the ability of some pharmacies to receive deliveries immediately following the cuts.
"The Guild recommends that members discuss with their wholesaler pre-1 October ordering, pricing arrangements and access to deliveries," said president George Tambassis in an update last Fri.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Aug 18
